As glycaemic variability on the one hand and hypoglycaemia on the other are associated with oxidative stress and inflammation, they are likely, in type-1 diabetic patients, to affect the oxidation of lipoproteins and HDL function, by altering their anti-atherogenic properties. The aim of this study is thus to determine, in patients with Type 1 Diabetic (T1D) who will wear a glycaemic Holter for 1 week, the glycaemia parameters (mean glycaemia, duration of hypoglycaemia, duration of hyperglycaemia, mean amplitude of glycaemic excursions) associated with proatherogenic alterations in lipoproteins, in particular: * LDL oxidation * HDL oxidation and alterations of HDL function (anti-inflammatory capacity, antioxidant capacity)
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Masking
NONE
Enrollment
60
CHU Dijon Bourgogne
Dijon, France
Average blood glucose
Time frame: through study completion, an average of 7 days
Time hypoglycemia
Time frame: through study completion, an average of 7 days
Time hyperglycemia
Time frame: through study completion, an average of 7 days
Amplitude of glycemic variations
Time frame: through study completion, an average of 7 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.